Shares of Canopy Growth Corp. WEED-T dropped by 40 per cent Friday after the company announced it was issuing new shares to reduce its debt load, just one day before a key debt maturity. Canopy said ...

September saw an intensification of pressure on the economy and markets. Interest rate hikes continued – foretelling economic woes and company troubles. In turn, this has exasperated investors’ ...

Canopy, based in Smiths Falls, Ont., produces and sells medical cannabis and cannabinoid-based consumer products in Canada ...

Canopy Growth reported improved financial results for Q2, with higher revenue and improved net loss. Find out why CGC stock ...

Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Canopy Growth's (NASDAQ: CGC) share price is getting hit hard in Wednesday's trading. The marijuana stock was down 23.2% as of 10:45 a.m. ET, according to data from S&P Global Market Intelligence.

Canadian cannabis stocks have taken investors on a roller-coaster ride in recent years. For instance, between January 2015 and 2019, shares of Canopy Growth (TSX:WEED) surged over 1,600% due to ...

Canopy Growth (CGC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Detailed price information for Canopy Growth Corp (CGC-Q) from The Globe and Mail including charting and trades.

Ottawa-area marijuana producer Canopy Growth Corp. (TSX:CGC) is offering to buy Mettrum Health Corp. (TSXV:MT) in a friendly all-stock deal valued at $430 million. Mettrum shareholders will be ...